Serveur d'exploration sur la grippe aux Pays-Bas

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases.

Identifieur interne : 000271 ( Main/Exploration ); précédent : 000270; suivant : 000272

Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases.

Auteurs : S. Hahné [Pays-Bas] ; T. Donker ; A. Meijer ; A. Timen ; J. Van Steenbergen ; A. Osterhaus ; M. Van Der Sande ; M. Koopmans ; J. Wallinga ; R. Coutinho

Source :

RBID : pubmed:19589332

Descripteurs français

English descriptors

Abstract

Introductions of the new influenza A(H1N1) variant virus in the Netherlands led to enhanced surveillance and infection control. By 24 June 2009, 115 cases were reported, of whom 44% were indigenously acquired. Severity of disease is similar to reports elsewhere. Our point estimate of the effective reproductive number (Re) for the initial phase of the influenza A(H1N1)v epidemic in the Netherlands was below one. Given that the Re estimate is based on a small number of indigenous cases and a limited time period, it needs to be interpreted cautiously.

DOI: 10.2807/ese.14.27.19267-en
PubMed: 19589332


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases.</title>
<author>
<name sortKey="Hahne, S" sort="Hahne, S" uniqKey="Hahne S" first="S" last="Hahné">S. Hahné</name>
<affiliation wicri:level="1">
<nlm:affiliation>Rijksinstituut voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment), Bilthoven, the Netherlands. Susan.Hahne@rivm.nl</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Rijksinstituut voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment), Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Donker, T" sort="Donker, T" uniqKey="Donker T" first="T" last="Donker">T. Donker</name>
</author>
<author>
<name sortKey="Meijer, A" sort="Meijer, A" uniqKey="Meijer A" first="A" last="Meijer">A. Meijer</name>
</author>
<author>
<name sortKey="Timen, A" sort="Timen, A" uniqKey="Timen A" first="A" last="Timen">A. Timen</name>
</author>
<author>
<name sortKey="Van Steenbergen, J" sort="Van Steenbergen, J" uniqKey="Van Steenbergen J" first="J" last="Van Steenbergen">J. Van Steenbergen</name>
</author>
<author>
<name sortKey="Osterhaus, A" sort="Osterhaus, A" uniqKey="Osterhaus A" first="A" last="Osterhaus">A. Osterhaus</name>
</author>
<author>
<name sortKey="Van Der Sande, M" sort="Van Der Sande, M" uniqKey="Van Der Sande M" first="M" last="Van Der Sande">M. Van Der Sande</name>
</author>
<author>
<name sortKey="Koopmans, M" sort="Koopmans, M" uniqKey="Koopmans M" first="M" last="Koopmans">M. Koopmans</name>
</author>
<author>
<name sortKey="Wallinga, J" sort="Wallinga, J" uniqKey="Wallinga J" first="J" last="Wallinga">J. Wallinga</name>
</author>
<author>
<name sortKey="Coutinho, R" sort="Coutinho, R" uniqKey="Coutinho R" first="R" last="Coutinho">R. Coutinho</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19589332</idno>
<idno type="pmid">19589332</idno>
<idno type="doi">10.2807/ese.14.27.19267-en</idno>
<idno type="wicri:Area/Main/Corpus">000260</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000260</idno>
<idno type="wicri:Area/Main/Curation">000260</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000260</idno>
<idno type="wicri:Area/Main/Exploration">000260</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases.</title>
<author>
<name sortKey="Hahne, S" sort="Hahne, S" uniqKey="Hahne S" first="S" last="Hahné">S. Hahné</name>
<affiliation wicri:level="1">
<nlm:affiliation>Rijksinstituut voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment), Bilthoven, the Netherlands. Susan.Hahne@rivm.nl</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Pays-Bas</country>
<wicri:regionArea>Rijksinstituut voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment), Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Donker, T" sort="Donker, T" uniqKey="Donker T" first="T" last="Donker">T. Donker</name>
</author>
<author>
<name sortKey="Meijer, A" sort="Meijer, A" uniqKey="Meijer A" first="A" last="Meijer">A. Meijer</name>
</author>
<author>
<name sortKey="Timen, A" sort="Timen, A" uniqKey="Timen A" first="A" last="Timen">A. Timen</name>
</author>
<author>
<name sortKey="Van Steenbergen, J" sort="Van Steenbergen, J" uniqKey="Van Steenbergen J" first="J" last="Van Steenbergen">J. Van Steenbergen</name>
</author>
<author>
<name sortKey="Osterhaus, A" sort="Osterhaus, A" uniqKey="Osterhaus A" first="A" last="Osterhaus">A. Osterhaus</name>
</author>
<author>
<name sortKey="Van Der Sande, M" sort="Van Der Sande, M" uniqKey="Van Der Sande M" first="M" last="Van Der Sande">M. Van Der Sande</name>
</author>
<author>
<name sortKey="Koopmans, M" sort="Koopmans, M" uniqKey="Koopmans M" first="M" last="Koopmans">M. Koopmans</name>
</author>
<author>
<name sortKey="Wallinga, J" sort="Wallinga, J" uniqKey="Wallinga J" first="J" last="Wallinga">J. Wallinga</name>
</author>
<author>
<name sortKey="Coutinho, R" sort="Coutinho, R" uniqKey="Coutinho R" first="R" last="Coutinho">R. Coutinho</name>
</author>
</analytic>
<series>
<title level="j">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</title>
<idno type="eISSN">1560-7917</idno>
<imprint>
<date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Disease Outbreaks (prevention & control)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (classification)</term>
<term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (virology)</term>
<term>Male (MeSH)</term>
<term>Netherlands (epidemiology)</term>
<term>Oseltamivir (administration & dosage)</term>
<term>Population Surveillance (MeSH)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction (MeSH)</term>
<term>Serotyping (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Antiviraux (administration et posologie)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (prévention et contrôle)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Oséltamivir (administration et posologie)</term>
<term>Pays-Bas (épidémiologie)</term>
<term>RT-PCR (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (classification)</term>
<term>Sous-type H1N1 du virus de la grippe A (isolement et purification)</term>
<term>Surveillance de la population (MeSH)</term>
<term>Sérotypie (MeSH)</term>
<term>Épidémies de maladies (prévention et contrôle)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Antiviral Agents</term>
<term>Oseltamivir</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Netherlands</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Antiviraux</term>
<term>Oséltamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Disease Outbreaks</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Grippe humaine</term>
<term>Épidémies de maladies</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Pays-Bas</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Population Surveillance</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Serotyping</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>RT-PCR</term>
<term>Surveillance de la population</term>
<term>Sérotypie</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Pays-Bas</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Introductions of the new influenza A(H1N1) variant virus in the Netherlands led to enhanced surveillance and infection control. By 24 June 2009, 115 cases were reported, of whom 44% were indigenously acquired. Severity of disease is similar to reports elsewhere. Our point estimate of the effective reproductive number (Re) for the initial phase of the influenza A(H1N1)v epidemic in the Netherlands was below one. Given that the Re estimate is based on a small number of indigenous cases and a limited time period, it needs to be interpreted cautiously.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">19589332</PMID>
<DateCompleted>
<Year>2009</Year>
<Month>09</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>06</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1560-7917</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>14</Volume>
<Issue>27</Issue>
<PubDate>
<Year>2009</Year>
<Month>Jul</Month>
<Day>09</Day>
</PubDate>
</JournalIssue>
<Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title>
<ISOAbbreviation>Euro Surveill.</ISOAbbreviation>
</Journal>
<ArticleTitle>Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">19267</ELocationID>
<Abstract>
<AbstractText>Introductions of the new influenza A(H1N1) variant virus in the Netherlands led to enhanced surveillance and infection control. By 24 June 2009, 115 cases were reported, of whom 44% were indigenously acquired. Severity of disease is similar to reports elsewhere. Our point estimate of the effective reproductive number (Re) for the initial phase of the influenza A(H1N1)v epidemic in the Netherlands was below one. Given that the Re estimate is based on a small number of indigenous cases and a limited time period, it needs to be interpreted cautiously.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hahné</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Rijksinstituut voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment), Bilthoven, the Netherlands. Susan.Hahne@rivm.nl</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Donker</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Meijer</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Timen</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>van Steenbergen</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Osterhaus</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>van der Sande</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Koopmans</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Wallinga</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Coutinho</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>Dutch New Influenza A(H1N1)v Investigation Team</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2009</Year>
<Month>07</Month>
<Day>09</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Sweden</Country>
<MedlineTA>Euro Surveill</MedlineTA>
<NlmUniqueID>100887452</NlmUniqueID>
<ISSNLinking>1025-496X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012703" MajorTopicYN="N">Serotyping</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Beaujean</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Beersma</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Boucher</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van Boven</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Brandsema</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>de Bruin</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Coutinho</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Deuning</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dijkstra</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dittrich</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Donker</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van Eijk</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van Gageldonk</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hahné</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>ten Ham</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van der Have</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van den Hoek</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van der Hoek</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Isken</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jacobi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jacobs</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jonges</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van den Kerkhof</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van Kessel</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koopmans</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kroneman</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van der Lubben</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Meijer</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Monen</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Osterhaus</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Petrignani</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ruijs</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van der Sande</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>ter Schegget</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schutten</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Siebbeles</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>van Steenbergen</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Steens</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Swaan</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Timen</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vennema</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Verhoef</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vriend</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Waegemaekers</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wallinga</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2009</Year>
<Month>7</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2009</Year>
<Month>7</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2009</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">19589332</ArticleId>
<ArticleId IdType="doi">10.2807/ese.14.27.19267-en</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Coutinho, R" sort="Coutinho, R" uniqKey="Coutinho R" first="R" last="Coutinho">R. Coutinho</name>
<name sortKey="Donker, T" sort="Donker, T" uniqKey="Donker T" first="T" last="Donker">T. Donker</name>
<name sortKey="Koopmans, M" sort="Koopmans, M" uniqKey="Koopmans M" first="M" last="Koopmans">M. Koopmans</name>
<name sortKey="Meijer, A" sort="Meijer, A" uniqKey="Meijer A" first="A" last="Meijer">A. Meijer</name>
<name sortKey="Osterhaus, A" sort="Osterhaus, A" uniqKey="Osterhaus A" first="A" last="Osterhaus">A. Osterhaus</name>
<name sortKey="Timen, A" sort="Timen, A" uniqKey="Timen A" first="A" last="Timen">A. Timen</name>
<name sortKey="Van Der Sande, M" sort="Van Der Sande, M" uniqKey="Van Der Sande M" first="M" last="Van Der Sande">M. Van Der Sande</name>
<name sortKey="Van Steenbergen, J" sort="Van Steenbergen, J" uniqKey="Van Steenbergen J" first="J" last="Van Steenbergen">J. Van Steenbergen</name>
<name sortKey="Wallinga, J" sort="Wallinga, J" uniqKey="Wallinga J" first="J" last="Wallinga">J. Wallinga</name>
</noCountry>
<country name="Pays-Bas">
<noRegion>
<name sortKey="Hahne, S" sort="Hahne, S" uniqKey="Hahne S" first="S" last="Hahné">S. Hahné</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000271 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000271 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippePaysBasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:19589332
   |texte=   Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:19589332" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippePaysBasV1 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 10:18:30 2020. Site generation: Sat Mar 27 13:53:34 2021